https://www.selleckchem.com/pr....oducts/baricitinib-l
l adverse events, increasing the opportunity of patient's early rehabilitation and discharge.OBJECTIVES To inform development of a core outcome set, we evaluated the scope and variability of outcomes, definitions, measures, and measurement time-points in published clinical trials of pharmacologic or nonpharmacologic interventions, including quality improvement projects, to prevent and/or treat delirium in the critically ill. DATA SOURCES We searched electronic databases, systematic review repositories, and trial registries
إعجاب
علق
شارك
